Liege, Belgium, 28 March 2024 – 08:00 CET – Mithra (Euronext Brussels: MITRA) (the “Company”), a company dedicated to women’s health, announces today updates to its financial calendar for 2024.
Considering the timeline of the previously announced Monetization Process, the Company, in agreement with its statutory auditor, has decided to postpone the publication of its Annual Report 2023 (which was initially envisaged to take place on 16 April 2024) to 30 April 2024, as by that time the Company expects to be in a position to provide more clarity and transparency on the ongoing Monetization Process.
For the same reason, the publication of the convening notice for the Company’s Annual General Meeting (with all legally required information) will be postponed to 30 April 2024, resulting in the postponement of the date of the Annual General Meeting from 16 May 2024 to the 30 May 2024. The financial calendar is thus adapted as follows:
- 8 March 2024: Full year results 2023 – completed
- 30 April 2024: Annual report 2023 (changed from 16 April 2024)
- 30 May 2024: General Shareholders’ Meeting (changed from 16 May 2024)
- 26 September 2024: Half year results 2024
The Company will continue to update the market as appropriate with respect to the Monetization Process.
The adapted financial calendar and all corporate information on the Company (financial statements, events or corporate presentations, …) are available on the Company’s website in the Investors’ section (mithra.com/en/investors).